Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $71.91 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $51.35 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.56 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.56 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($20.56) |
| 2019 | $51.35 | 1 | Novo Nordisk Inc ($51.35) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: DIABETES | ||||||
| 08/29/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $51.35 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 49 | 85 | $2,289 | $548.38 |
| 2022 | 2 | 25 | 29 | $721.00 | $174.91 |
| 2021 | 2 | 42 | 63 | $1,699 | $415.21 |
| 2020 | 3 | 59 | 96 | $2,272 | $554.58 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 39 | $1,599 | $371.28 | 23.2% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 24 | 46 | $690.00 | $177.10 | 25.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 11 | $451.00 | $105.29 | 23.3% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 14 | 18 | $270.00 | $69.62 | 25.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 23 | 29 | $1,189 | $281.59 | 23.7% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 19 | 34 | $510.00 | $133.62 | 26.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 23 | 32 | $1,312 | $309.77 | 23.6% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 24 | 52 | $780.00 | $203.40 | 26.1% |
| 81002 | Urinalysis, manual test | Office | 2020 | 12 | 12 | $180.00 | $41.41 | 23.0% |
About Dr. Ervin Anthony, MD
Dr. Ervin Anthony, MD is a Emergency Medicine healthcare provider based in Mathews, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114920253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ervin Anthony, MD has received a total of $71.91 in payments from pharmaceutical and medical device companies, with $20.56 received in 2023. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($71.91).
As a Medicare-enrolled provider, Anthony has provided services to 175 Medicare beneficiaries, totaling 273 services with total Medicare billing of $1,693. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Mathews, VA
- Active Since 05/23/2005
- Last Updated 05/31/2019
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1114920253
Products in Payments
- Saxenda (Drug) $51.35
- JARDIANCE (Drug) $20.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.